Parenteral 17beta-estradiol decreases fasting blood glucose levels in non-obese mice with short-term ovariectomy

Life Sciences

Volumn 87, Issue 11-12, 2010, Pages 358-366

  Kim, Ju Young ^a   Jo, Kyung Jin ^b   Kim, Ok Soon ^b   Kim, Byung Joon ^a   Kang, Dong Wook ^b   Lee, Ki Ho ^b   Baik, Haing Woon ^b   Han, Min Soo ^b   Lee, Seong Kyu ^b  

^a Konyang University College of Medicine   (South Korea)

^b Eulji University   (South Korea)

Author keywords

17beta Estradiol; AMP activated protein kinase; Fasting blood glucose; Gluconeogenic gene; Insulin signaling

Indexed keywords

ADENYLATE KINASE; ESTRADIOL; GLUCOSE; GLUCOSE 6 PHOSPHATASE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); ACETYL COENZYME A CARBOXYLASE; ADIPONECTIN; ADIPOQ PROTEIN, MOUSE; CARNITINE PALMITOYLTRANSFERASE; ESTROGEN; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN RECEPTOR SUBSTRATE; ION CHANNEL; IRS1 PROTEIN, MOUSE; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 2; PPARGC1A PROTEIN, MOUSE; PROTEIN KINASE B; RESISTIN; RETN PROTEIN, MOUSE; SLC2A4 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER; MOUSE; NONHUMAN; OVARIECTOMY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WHITE ADIPOSE TISSUE; ADIPOSE TISSUE; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INTRAABDOMINAL FAT; METABOLISM; OBESITY; ORGAN SIZE; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; TIME; UTERUS;

ACETYL-COA CARBOXYLASE; ADIPONECTIN; ADIPOSE TISSUE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CARNITINE O-PALMITOYLTRANSFERASE; ENZYME ACTIVATION; ESTRADIOL; ESTROGENS; FASTING; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; GLUCOSE-6-PHOSPHATASE; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; ION CHANNELS; LIVER; MICE; MICE, INBRED C57BL; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; OBESITY; ORGAN SIZE; OVARIECTOMY; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RESISTIN; SIGNAL TRANSDUCTION; TIME FACTORS; TRANS-ACTIVATORS; UTERUS; TRANSCRIPTION FACTORS;

MUS;

EID: 77956400845     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.07.009     Document Type: Article

References (49)

1. Banerjee R.R., Rangwala S.M., Shapiro J.S., Rich A.S., Rhoades B., Qi Y., Wang J., Rajala M.W., Pocai A., Scherer P.E., Steppan C.M., Ahima R.S., Obici S., Rossetti L., Lazar M.A. Regulation of fasted blood glucose by resistin. Science 2004, 303(5661):1195-1198.
2. Barthel A., Schmoll D. Novel concepts in insulin regulation of hepatic gluconeogenesis. American Journal of Physiology. Endocrinology and Metabolism 2003, 285(4):E685-E692.
3. Bell G.I., Polonsky K.S. Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 2001, 414(6865):788-791.
4. Campbell S.E., Febbraio M.A. Effect of ovarian hormones on mitochondrial enzyme activity in the fat oxidation pathway of skeletal muscle. American Journal of Physiology. Endocrinology and Metabolism 2001, 281(4):E803-E808.
5. Campbell S.E., Mehan K.A., Tunstall R.J., Febbraio M.A., Cameron-Smith D. 17beta-estradiol upregulates the expression of peroxisome proliferator-activated receptor alpha and lipid oxidative genes in skeletal muscle. Journal of Molecular Endocrinology 2003, 31(1):37-45.
6. Christ B., Nath A., Jungermann K. Mechanism of the impairment of the glucagon-stimulated phosphoenolpyruvate carboxykinase gene expression by interleukin-6 in rat hepatocytes: inhibition of the increase in cyclic 3', 5' adenosine monophosphate and the downstream cyclic 3', 5' adenosine monophosphate action. Hepatology 1997, 26(1):73-80.
7. Dandona P., Aljada A., Chaudhuri A., Mohanty P., Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005, 111(11):1448-1454.
8. D'Eon T.M., Rogers N.H., Stancheva Z.S., Greenberg A.S. Estradiol and the estradiol metabolite, 2-hydroxyestradiol, activate AMP-activated protein kinase in C2C12 myotubes. Obesity (Silver Spring) 2008, 16(6):1284-1288.
9. D'Eon T.M., Souza S.C., Aronovitz M., Obin M.S., Fried S.K., Greenberg A.S. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. The Journal of Biological Chemistry 2005, 280(43):35983-35991.
10. Dobbins R.L., Szczepaniak L.S., Bentley B., Esser V., Myhill J., McGarry J.D. Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Diabetes 2001, 50(1):123-130.
11. Faure A., Sutter-Dub M.T., Sutter B.C., Assan R. Ovarian-adrenal interactions in regulation of endocrine pancreatic function in the rat. Diabetologia 1983, 24(2):122-127.
12. Godsland I.F. Oestrogens and insulin secretion. Diabetologia 2005, 48(11):2213-2220.
13. Gui Y., Silha J.V., Murphy L.J. Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obesity Research 2004, 12(9):1481-1491.
14. Haffner S.M., Miettinen H., Stern M.P. The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997, 20(7):1087-1092.
15. Horike N., Takemori H., Katoh Y., Doi J., Min L., Asano T., Sun X.J., Yamamoto H., Kasayama S., Muraoka M., Nonaka Y., Okamoto M. Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2. The Journal of Biological Chemistry 2003, 278(20):18440-18447.
16. Jäger S., Handschin C., St-Pierre J., Spiegelman B.M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. PNAS 2007, 104(29):12017-12022.
17. Kim J.Y., Hickner R.C., Cortright R.L., Dohm G.L., Houmard J.A. Lipid oxidation is reduced in obese human skeletal muscle. American Journal of Physiology. Endocrinology and Metabolism 2000, 279(5):E1039-E1044.
18. Koricanac G., Milosavljevic T., Stojiljkovic M., Zakula Z., Ribarac-Stepic N., Isenovic E.R. Insulin signaling in the liver and uterus of ovariectomized rats treated with estradiol. The Journal of Steroid Biochemistry Molecular Biology 2008, 108(1-2):109-116.
19. Kurth-Kraczek E.J., Hirshman M.F., Goodyear L.J., Winder W.W. 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 1999, 48(8):1667-1671.
20. Lage R., Diéguez C., Vidal-Puig A., López M. AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends in Molecular Medicine 2008, 14(12):539-549.
21. Lagro-Janssen A., Knufing M., Schreurs L., van Weel C. Significant fall in hormone replacement therapy prescription in general practice. Family Practice 2010, 27(4):424-429.
22. Lee S., Muniyappa R., Yan X., Chen H., Yue L.Q., Hong E.G., Kim J.K., Quon M.J. Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice. American Journal of Physiology. Endocrinology and Metabolism 2008, 294(2):E261-270.
23. Liang Y.Q., Akishita M., Kim S., Ako J., Hashimoto M., Iijima K., Ohike Y., Watanabe T., Sudoh N., Toba K., Yoshizumi M., Ouchi Y. Estrogen receptor beta is involved in the anorectic action of estrogen. International Journal of Obesity and Related Metabolic Disorders 2002, 26(8):1103-1109.
24. Liu M.L., Xu X., Rang W.Q., Li Y.J., Song H.P. Influence of ovariectomy and 17beta-estradiol treatment on insulin sensitivity, lipid metabolism and post-ischemic cardiac function. International Journal of Cardiology 2004, 97(3):485-493.
25. Lobo R.A. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008, 60(1):10-18.
26. Louet J.F., Hayhurst G., Gonzalez F.J., Girard J., Decaux J.F. The coactivator PGC-1 is involved in the regulation of the liver carnitine palmitoyltransferase I gene expression by cAMP in combination with HNF4 alpha and cAMP-response element-binding protein (CREB). The Journal of Biological Chemistry 2002, 277(41):37991-38000.
27. Manson J.E., Rimm E.B., Colditz G.A., Willett W.C., Nathan D.M., Arky R.A., Rosner B., Hennekens C.H., Speizer F.E., Stampfer M.J. A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus. Annals of Epidemiology 1992, 2(5):665-673.
28. Paquette A., Shinoda M., Rabasa Lhoret R., Prud'homme D., Lavoie J.M. Time course of liver lipid infiltration in ovariectomized rats: impact of a high-fat diet. Maturitas 2007, 58(2):182-190.
29. Park Y.W., Zhu S., Palaniappan L., Heshka S., Carnethon M.R., Heymsfield S.B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Archives of International Medicine 2003, 163(4):427-436.
30. Pecqueur C., Couplan E., Bouillaud F., Ricquier D. Genetic and physiological analysis of the role of uncoupling proteins in human energy homeostasis. Journal of Molecular Medicine 2001, 79(1):48-56.
31. Pentti K., Tuppurainen M.T., Honkanen R., Sandini L., Kröger H., Alhava E., Saarikoski S. Hormone therapy protects from diabetes: the Kuopio osteoporosis risk factor and prevention study. European Journal of Endocrinology 2009, 160(6):979-983.
32. Postic C., Dentin R., Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes and Metabolism 2004, 30(5):398-408.
33. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92(6):829-839.
34. Puigserver P., Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocrine Reviews 2003, 24(1):78-90.
35. Riant E., Waget A., Cogo H., Arnal J.F., Burcelin R., Gourdy P. Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology 2009, 150(5):2109-2117.
36. Rogers N.H., Witczak C.A., Hirshman M.F., Goodyear L.J., Greenberg A.S. Estradiol stimulates Akt, AMP-activated protein kinase (AMPK) and TBC1D1/4, but not glucose uptake in rat soleus. Biochemical and Biophysical Research Communications 2009, 382(4):646-650.
37. Ropero A.B., Soria B., Nadal A. A nonclassical estrogen membrane receptor triggers rapid differential actions in the endocrine pancreas. Molecular Endocrinology 2002, 16(3):497-505.
38. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. The Journal of the American Medical Association 2002, 288(3):321-333.
39. Ruderman N., Prentki M. AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nature Reviews. Drug Discovery 2004, 3(4):340-351.
40. Ryder J.W., Gilbert M., Zierath J.R. Skeletal muscle and insulin sensitivity: pathophysiological alterations. Frontiers in bioscience 2001, 6:D154-163.
41. Saengsirisuwan V., Pongseeda S., Prasannarong M., Vichaiwong K., Toskulkao C. Modulation of insulin resistance in ovariectomized rats by endurance exercise training and estrogen replacement. Metabolism 2009, 58(1):38-47.
42. Saleh M.C., Wheeler M.B., Chan C.B. Uncoupling protein-2: evidence for its function as a metabolic regulator. Diabetologia 2002, 45(2):174-187.
43. Saltiel A.R., Kahn C.R. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 2001, 414(6865):799-806.
44. Shaw R.J., Lamia K.A., Vasquez D., Koo S.H., Bardeesy N., Depinho R.A., Montminy M., Cantley L.C. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005, 310(5754):1642-1646.
45. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., Lazar M.A. The hormone resistin links obesity to diabetes. Nature 2001, 409(6818):307-312.
46. Suzuki A., Urushitani H., Watanabe H., Sato T., Iguchi T., Kobayashi T., Ohta Y. Comparison of estrogen responsive genes in the mouse uterus, vagina and mammary gland. The Journal of Veterinary Medical Science 2007, 69(7):725-731.
47. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., Troy A., Cinti S., Lowell B., Scarpulla R.C., Spiegelman B.M. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999, 98(1):115-124.
48. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N., Ezaki O., Akanuma Y., Gavrilova O., Vinson C., Reitman M.L., Kagechika H., Shudo K., Yoda M., Nakano Y., Tobe K., Nagai R., Kimura S., Tomita M., Froguel P., Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine 2001, 7(8):941-946.
49. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., Froguel P., Foufelle F., Ferre P., Carling D., Kimura S., Nagai R., Kahn B.B., Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine 2002, 8(11):1288-1295.